Thrombopoietin stimulating agents

Nonpeptide mimetic eltrombopag and peptibody romiplostim.

Eltombopag and romiplostim have efficacy in short and long-term studies of immune thrombocytopenic purpura.

Thrombopoietin receptors are present in early hematopoietic progenitors, and studies suggest thrombopoietin stimulating agents can stimulate myeloid blasts.

Leave a Reply

Your email address will not be published. Required fields are marked *